{
     "PMID": "28825787",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20180130",
     "LR": "20180226",
     "IS": "1948-7193 (Electronic) 1948-7193 (Linking)",
     "VI": "8",
     "IP": "12",
     "DP": "2017 Dec 20",
     "TI": "Structural Determinants of the gamma-8 TARP Dependent AMPA Receptor Antagonist.",
     "PG": "2631-2647",
     "LID": "10.1021/acschemneuro.7b00186 [doi]",
     "AB": "The forebrain specific AMPA receptor antagonist, LY3130481/CERC-611, which selectively antagonizes the AMPA receptors associated with TARP gamma-8, an auxiliary subunit enriched in the forebrain, has potent antiepileptic activities without motor side effects. We designated the compounds with such activities as gamma-8 TARP dependent AMPA receptor antagonists (gamma-8 TDAAs). In this work, we further investigated the mechanisms of action using a radiolabeled gamma-8 TDAA and ternary structural modeling with mutational validations to characterize the LY3130481 binding to gamma-8. The radioligand binding to the cells heterologously expressing GluA1 and/or gamma-8 revealed that gamma-8 TDAAs binds to gamma-8 alone without AMPA receptors. Homology modeling of gamma-8, based on the crystal structures of a distant TARP homologue, murine claudin 19, in conjunction with knowledge of two gamma-8 residues previously identified as critical for the LY3130481 TARP-dependent selectivity provided the basis for a binding mode prediction. This allowed further rational mutational studies for characterization of the structural determinants in TARP gamma-8 for LY3130481 activities, both thermodynamically as well as kinetically.",
     "FAU": [
          "Lee, Matthew R",
          "Gardinier, Kevin M",
          "Gernert, Douglas L",
          "Schober, Douglas A",
          "Wright, Rebecca A",
          "Wang, He",
          "Qian, Yuewei",
          "Witkin, Jeffrey M",
          "Nisenbaum, Eric S",
          "Kato, Akihiko S"
     ],
     "AU": [
          "Lee MR",
          "Gardinier KM",
          "Gernert DL",
          "Schober DA",
          "Wright RA",
          "Wang H",
          "Qian Y",
          "Witkin JM",
          "Nisenbaum ES",
          "Kato AS"
     ],
     "AD": "Lilly Biotechnology Center, Eli Lilly and Company , 10300 Campus Point Dr. #200, San Diego, California 92121, United States. Neuroscience Discovery, Lilly Research Laboratory , 355 E Merril St., Indianapolis, Indiana 46285, United States. Neuroscience Discovery, Lilly Research Laboratory , 355 E Merril St., Indianapolis, Indiana 46285, United States. Neuroscience Discovery, Lilly Research Laboratory , 355 E Merril St., Indianapolis, Indiana 46285, United States. Neuroscience Discovery, Lilly Research Laboratory , 355 E Merril St., Indianapolis, Indiana 46285, United States. Neuroscience Discovery, Lilly Research Laboratory , 355 E Merril St., Indianapolis, Indiana 46285, United States. Neuroscience Discovery, Lilly Research Laboratory , 355 E Merril St., Indianapolis, Indiana 46285, United States. Neuroscience Discovery, Lilly Research Laboratory , 355 E Merril St., Indianapolis, Indiana 46285, United States. Neuroscience Discovery, Lilly Research Laboratory , 355 E Merril St., Indianapolis, Indiana 46285, United States. Neuroscience Discovery, Lilly Research Laboratory , 355 E Merril St., Indianapolis, Indiana 46285, United States.",
     "AUID": [
          "ORCID: 0000-0001-8238-5781"
     ],
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20170905",
     "PL": "United States",
     "TA": "ACS Chem Neurosci",
     "JT": "ACS chemical neuroscience",
     "JID": "101525337",
     "RN": [
          "0 (Benzothiazoles)",
          "0 (LY3130481)",
          "0 (Pyrazoles)",
          "0 (Receptors, AMPA)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Benzothiazoles/*chemistry",
          "Binding Sites",
          "Hippocampus/chemistry",
          "Male",
          "Mice",
          "Models, Biological",
          "Models, Chemical",
          "*Molecular Docking Simulation",
          "Neurons/*chemistry",
          "Protein Binding",
          "Protein Conformation",
          "Pyrazoles/*chemistry",
          "Receptors, AMPA/*antagonists & inhibitors/*ultrastructure",
          "Structure-Activity Relationship"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "*Structural modeling",
          "*TDAA",
          "*glutamate receptor",
          "*ionotropic",
          "*stargazer",
          "*stargazin"
     ],
     "EDAT": "2017/08/22 06:00",
     "MHDA": "2018/01/31 06:00",
     "CRDT": [
          "2017/08/22 06:00"
     ],
     "PHST": [
          "2017/08/22 06:00 [pubmed]",
          "2018/01/31 06:00 [medline]",
          "2017/08/22 06:00 [entrez]"
     ],
     "AID": [
          "10.1021/acschemneuro.7b00186 [doi]"
     ],
     "PST": "ppublish",
     "SO": "ACS Chem Neurosci. 2017 Dec 20;8(12):2631-2647. doi: 10.1021/acschemneuro.7b00186. Epub 2017 Sep 5.",
     "term": "hippocampus"
}